---
figid: PMC4082184__nihms588374f2
figlink: /pmc/articles/PMC4082184/figure/F2/
number: F2
caption: 'PHLPP (center) directly dephosphorylates and inactivates AKT, PKC, and S6K,
  at their hydrophobic phosphorylation motif (green circle) thus opposing cell survival
  and growth signals, and directly dephosphorylates and activates Mst1 at an inhibitory
  site (red circle), thus promoting pro-apoptotic signals. Indicated are two negative
  feedback loops which control the steady-state levels of PHLPP: high AKT activity
  up regulates PHLPP levels by suppressing GSK-3-dependent degradation, and high S6K
  activity up regulates PHLPP expression. Note that targeting the PI3 kinase pathway
  within these feedback loops will have the consequence of decreasing PHLPP levels,
  thus promoting pro-survival pathways mediated by PKC and inhibiting pro-apoptotic
  pathways mediated by Mst1. The lipid phosphatase PTEN opposes the lipid kinase phosphatidylinositol
  3 kinase (PI3K) by dephosphorylating PIP3 and the lipid kinase DG kinase opposes
  phospholipase C by phosphorylating DG. Scaffolds play an essential role in controlling
  substrate specificity of PHLPP and are indicated in grey. Also shown is the negative
  feedback loop from S6K to the scaffold IRS-1, which dampens PI3K activation and
  hence AKT activation (see  also). Inset shows conserved domain structure of mammalian
  PHLPP family members showing PH domain (cyan), Leucine-rich repeats (LRR; orange),
  PP2C domain (green), and C-terminal PDZ-binding motif (pink); PHLPP1β and PHLPP2
  also have a predicted RA domain preceding the PH domain (not shown).'
pmcid: PMC4082184
papertitle: 'Turning Off AKT: PHLPP as a Drug Target.'
reftext: Alexandra C. Newton, et al. Annu Rev Pharmacol Toxicol. ;54:537-558.
pmc_ranked_result_index: '131882'
pathway_score: 0.968378
filename: nihms588374f2.jpg
figtitle: 'Turning Off AKT: PHLPP as a Drug Target'
year: ''
organisms:
- Homo sapiens
ndex: 615275e9-decc-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4082184__nihms588374f2.html
  '@type': Dataset
  description: 'PHLPP (center) directly dephosphorylates and inactivates AKT, PKC,
    and S6K, at their hydrophobic phosphorylation motif (green circle) thus opposing
    cell survival and growth signals, and directly dephosphorylates and activates
    Mst1 at an inhibitory site (red circle), thus promoting pro-apoptotic signals.
    Indicated are two negative feedback loops which control the steady-state levels
    of PHLPP: high AKT activity up regulates PHLPP levels by suppressing GSK-3-dependent
    degradation, and high S6K activity up regulates PHLPP expression. Note that targeting
    the PI3 kinase pathway within these feedback loops will have the consequence of
    decreasing PHLPP levels, thus promoting pro-survival pathways mediated by PKC
    and inhibiting pro-apoptotic pathways mediated by Mst1. The lipid phosphatase
    PTEN opposes the lipid kinase phosphatidylinositol 3 kinase (PI3K) by dephosphorylating
    PIP3 and the lipid kinase DG kinase opposes phospholipase C by phosphorylating
    DG. Scaffolds play an essential role in controlling substrate specificity of PHLPP
    and are indicated in grey. Also shown is the negative feedback loop from S6K to
    the scaffold IRS-1, which dampens PI3K activation and hence AKT activation (see  also).
    Inset shows conserved domain structure of mammalian PHLPP family members showing
    PH domain (cyan), Leucine-rich repeats (LRR; orange), PP2C domain (green), and
    C-terminal PDZ-binding motif (pink); PHLPP1β and PHLPP2 also have a predicted
    RA domain preceding the PH domain (not shown).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - AKT1
  - MTOR
  - PRKD3
  - NMUR1
  - PTEN
  - PLCD4
  - PRKCA
  - AKT3
  - PRKCE
  - GSK3A
  - PLCZ1
  - PLCD1
  - PLCG2
  - PLCB2
  - MST1
  - PIK3CG
  - PIK3R3
  - PLCG1
  - PRKCH
  - PRKCI
  - PIK3CA
  - PRKCQ
  - PIK3R6
  - PRKCD
  - RPTOR
  - PLCB3
  - IRS1
  - PRKCZ
  - PIK3CD
  - PLCB4
  - PHLPP1
  - PLCE1
  - PRKCG
  - PIK3CB
  - GSK3B
  - PRKCB
  - PLCB1
  - PLCD3
  - PIK3R4
  - PIK3R5
  - Cancer
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: GPCR
  symbol: GPC-R
  source: hgnc_alias_symbol
  hgnc_symbol: NMUR1
  entrez: '10316'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: GSK-3)
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: Mst-1
  symbol: MST1
  source: hgnc_symbol
  hgnc_symbol: MST1
  entrez: '4485'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PHLPP
  symbol: PHLPP
  source: hgnc_prev_symbol
  hgnc_symbol: PHLPP1
  entrez: '23239'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: GSK-3)
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4082184__F2
redirect_from: /figures/PMC4082184__F2
figtype: Figure
---
